Our mission is to contribute to the well-being of our customers and society as a whole. We aim to make "productive aging" a global reality based on scientific evidence.

In about 40 years, the world population will exceed 10 billion, while the number of births drop and the aging rate in developed regions will reach 27.6% (1). Japan, whose aged population has already exceeded 28%, faces the new challenge of extending health life expectancy, as the absolute life expectancy increases due to advances in medical technology.

In view of this situation, we were the first to commercialize NMN (2), developing a whole range of nutraceuticals (that is, health food based on scientific evidence, more reliable than supplements), while also making donations to different institutions.

How far can science expand the possibilities of humankind?
How far can we enjoy the benefits of science in our lives?
MIRAILAB BIOSCIENCE makes proposals that will lead to the improvement of society’s quality of life.

Today’s Vanguard Knowledge of Humankind for Tomorrow’s You.

(1) Chapter 1. About aging (Section 1-2) International Trends in Aging (Government of Japan)
(2) NMN (β-nicotinamide mononucleotide): belongs to the family of the B3 vitamins. It is of capital importance as a precursor of the coenzyme NAD (nicotinamide adenine dinucleotide).

Mirailab Bioscience’s Research Partners

■University of Washington in St. Louis, School of Medicine
■Professor Shin-ichiro Imai’s Laboratory, Department of Developmental Biology and Medicine (joint), Washington University in St. Louis, Missouri, USA
■Institute for Research on Productive Aging (IRPA)
■The Systems Biology
■Yamaguchi University School of Medicine, Graduate School
■Yamaguchi University School of Veterinary Medicine